Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of albuvirtide with lopinavir/ritonavir in HIV-infected adults
ChiCTR-TRC-13003140Phase 2Completed
- Sponsor
- Beijing YouAn Hospital
- Start
- Apr 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label trial of albuvirtide, lopinavir and ritonavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Beijing YouAn Hospital. Primary endpoint: Pharmacokinetic indices. Started Apr 2013; status: completed.
02
Drugs
albuvirtidelopinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ChiCTR-TRC-13003140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003140.